LICOSER plus

Food supplement based on serenoa repens, lycopene, camelia sinensis, urtica dioica; adjuvant in maintaining the physiological properties of the prostate gland.
Does not contain gluten or sugar.
       Serenoa Repens (synonym of Sabal Serrulata)
A plant widespread in the United States, Southern Europe and North Africa. The most important chemical constituents are different sterols, free fatty acids, carotenoids, essential oils and polysaccharides.
Useful for the proper functioning of the urinary tract and prostate.
       Lycopene
A natural pigment belonging to the class of carotenoids, it is characterized by antioxidant properties similar to those of beta-carotene, but it is much more powerful, and therefore much more effective in preventing damage from oxygen free radicals. In nature, Lycopene is present in tomatoes and other plant substances; endowed with high antioxidant activity, it is considered among the carotenoids to be the most powerful scavenger of oxygen free radicals.
       Urtica Dioica
A perennial herbaceous plant, native to Western Asia, widespread in all temperate regions, including Italy. In modern phytotherapy, the root plays a prominent role, in fact it is rich in phytosterols (α-sitosterol, daucosterol and related glucosides), with a mechanism of action similar to that of Serenoa but also contains lecithins (scopoletin) which inhibit EGF (Epidermal Growth Factor) a cell growth factor capable of reducing symptoms and partially also the volume of the gland. Therefore, Urtica Dioica root extract is of particular benefit in limiting androgen-induced prostatic tissue growth and in particular dihydrotestosterone.
       Green Tea
It is obtained from the leaf buds and young leaves of the plant known by the scientific name Camelia sinensis. The peculiarity of this plant is given by its high antioxidant potential.

Ingredients

	per 1 tablet (1300 mg)
Serenoa Repens (dry extract 45% fatty acids)	450 mg
Urtica dioica dry extract (Radix)	300 mg
Green Tea (Catechins)	100 mg
Lycopene	10 mg

Instructions for use
It is recommended to take 1 tablet daily before meals for a period of no less than 3/4 months.

Warnings
Do not exceed the recommended daily dose. Keep out of reach of children under 3 years of age. Supplements are not intended as a substitute for a varied diet. For pregnant or breastfeeding women and children, it is recommended to consult a doctor.

Format
Pack of 30 tablets of 1,300 mg.

Cod. 1010020.

Bibliography
  -   Carilla E,Briley M,Fauran F,Sultan C,Duvilliers C. Binding of Permixon,a new treatment for prostatic benign hyperplasia,to the cytosolic androgen receptor in the rat prostate.J Steroid Biochem 1984;20:521-3.
  -   Champault G,Patel JC,Bonnard QAM. A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia.Br J Clin Pharmacol 1984;18:461-2.
  -   De Bruyne F. et al. Evaluation of the clinical benefit Serenoa Repens and Tamsulosin in severe BPH patients-Personal study subset analysis.Eur.Urol. 2004 Jun;45(6):773-9;Discussion 779-80,2004.
  -   Boyle P,Robertson C,lowe F,Roehrborn C. Meta-analysis of clinical trials of Permixon in the treatmentof symptomatic benign prostatic hyperplasia.Urology 2000;55:533-9.
  -   Bent S. et al. Saw Palmetto for benign prostatic hyperplasya. N.Engl.J. Med. 354(6):557- 66,2006.
  -   Wilt T,Ishani A,Stark G,Mac donald R,Mulrow C,Lau J.Serenoa repens for benign prostatic hyperplasia.Cochrane Database Syst Rev 2000;2:CD001423.
  -   Fong YK, Milani S, Djavan B, Role of phytotherapy in men with lower urinary tract symptoms. Curr opin urol.2005; 15(1); 45-48.
 -   Wilt T, Ishani A, Mac Donald R, Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev,2002; 3 ; CDCD001423.
  -   Strauch G, Perles P, Vergult G, et al. Comparison of finasteride and Serenoa repens in the inhibition of 5-alpha reductase in healthy male volunteers. Eur.Urology 1994; 26:3, 247-252.
  -   Debruyne F, Boyle P, Calais da Silva F, Gillenwater JG, Hamdy FC, Perrin P, Teillac P, Vela- Navarrete R, Raynaud JP, Schulman C, Evalutation of the clinical benefit of permixon and tamsulosin in severe BPH patiens- PERMAL study subset analysis. Prog Urol, 2004 Jun;14(3):326-331.
  -   Avins A.L. et al. A detailed safety assestment of a Saw Palmetto extract. Complement ther med. 16(3):147-154,2008.
  -   Levy J.,Bosin E. Et al.,Lycopene is a more potent inhibitor of human cancer cell proliferation than either a-carotene or b- carotene.Nutr. Cancer,1995;24: 257-266.
  -   Sökeland J. Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia:analysis of prostate volume and therapeutic outcome. BJU int 200; 86(4):439-442.
  -   Schneider T, Rubben H, Stinging nettle root extract in long term treatment of benign prostatic syndrome (BPS).Results of a randomized, duble-blind,placebo controlled multicenter study after 12 months. Urologe A, 2004; 43(3): 302-306.
  -   Lichius JJ, The inhibiting effects of components of stinging nettle roots on experimentally induced prostatic i hyperplasia in mice. Planta Med,1999;65,7: 666-668.
  -   Bombardelli E, Morazzoni P, Urtica Dioica L. Fitoterapia 1997; 68,5, 387-402.
  -   Chem Pharm, Bulletin 38-1990.
  -   Kurahashi N, Inoue M, Iwasaki M, Sasazuki S, Tsugane AS, Japan Public Health Center- Based Prospective Study Group. Dairy product, satured fatty acid, and calcium intake and prostate cancer in a prospective cohort of Japanese men. Cancer Epidemiol Biomarkers Prev, 2008 Apr; 17 (4): 930-937.
  -   Betuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A, Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. cancer Res,2006 Jan 15;66(2): 1234-1240.
  -   Etminan M, Takkouche B, Caamano-Isorna F The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev, 2004 Mar; 13 (3): 340-345.
  -   Michael B. Sporn and Karen T. Liby Is Lycopene an effective Agent for preventing prostate cancer Cancer Prevention Research 14-03-2013.